Reaktion #51550

ord-abb1815bf724446a82122d9cfef3ad9c

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Waschenwashed with water and brine
  2. 2
    Trocknendried (MgSO4)
  3. 3
    Einengenconcentrated
  4. 4
    SonstigeThe residue was purified by preparative HPLC (
  5. 5
    WaschenC18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA) and the product
  6. 6
    workup.ADDITIONcontaining fractions
  7. 7
    Einengenwere concentrated, free-based with aq ammonium hydroxide
  8. 8
    Extraktionextracted with chloroform
  9. 9
    Waschenwashed with brine
  10. 10
    Trocknendried (K2CO3)
  11. 11
    Einengenconcentrated

Vorschrift

To a solution of 1-{2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-[1,4]oxazepino[6,5,4-hi]pyrido[4,3-b]indol-6-ylamino]-5-methylphenyl} ethanone from EXAMPLE 116 (20 mg, 0.05 mmol) in 5 ml methanol at 0° C. was added sodium borohydride (5.5 mg, 0.15 mmol). The solution was stirred with warming to room temperature for 2 h. The reaction was diluted with ethyl acetate, washed with water and brine, dried (MgSO4) and concentrated. The residue was purified by preparative HPLC (C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA) and the product containing fractions were concentrated, free-based with aq ammonium hydroxide, extracted with chloroform, washed with brine, dried (K2CO3) and concentrated to afford the title compound of EXAMPLE 117 as a mixture of diastereomers at the alcohol center. LRMS (ES)+: 380.3 (M+H)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US06849619B2uspto-grants-2005_02